Read + Share
Taguchi S. Editorial comment from Dr Taguchi to Real world evidence of enfortumab vedotin in
patients with advanced urothelial cancer: A multicenter observational study. Int J Urol 2024;31:348.
PMID: 38183313
|
 |
|
Taguchi S. Editorial comment from Dr Taguchi to Real world evidence of enfortumab vedotin in
patients with advanced urothelial cancer: A multicenter observational study. Int J Urol 2024;31:348.
PMID: 38183313
|
|
|
|